Syntheses of Mono- and Divalent C-Aminoglycosides Using 1,2-Oxazine Chemistry and Olefin Metathesis

Maja Kandziora; Eike Mucha; Sina P. Zucker; Hans-Ulrich Reissig

doi:10.1055/s-0034-1379503

Synlett, Inhaltsverzeichnis

Synlett 2015; 26(03): 367-374
DOI: 10.1055/s-0034-1379503

letter

Syntheses of Mono- and Divalent C-Aminoglycosides Using 1,2-Oxazine Chemistry and Olefin Metathesis

Maja Kandziora

Freie Universität Berlin, Institut für Chemie und Biochemie, Takustrasse 3, 14195 Berlin, Germany eMail: hans.reissig@chemie.fu-berlin.de

,

Eike Mucha

Freie Universität Berlin, Institut für Chemie und Biochemie, Takustrasse 3, 14195 Berlin, Germany eMail: hans.reissig@chemie.fu-berlin.de

,

Sina P. Zucker

Freie Universität Berlin, Institut für Chemie und Biochemie, Takustrasse 3, 14195 Berlin, Germany eMail: hans.reissig@chemie.fu-berlin.de

,

Hans-Ulrich Reissig*

Freie Universität Berlin, Institut für Chemie und Biochemie, Takustrasse 3, 14195 Berlin, Germany eMail: hans.reissig@chemie.fu-berlin.de

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

An approach to mono- and divalent C-aminoglycosides starting from a new enantiopure 1,2-oxazine derivative is described. The introduction of a vinyl group into the 1,3-dioxolanyl substituent of a 1,2-oxazine allowed the Lewis acid promoted preparation of a vinyl-substituted bicyclic 1,2-oxazinone. After reduction of the carbonyl group, exhaustive hydrogenolysis provided branched C-aminoglycosides either with β-d-talose or β-d-idose configuration. The vinyl group of the protected rearrangement product 8 also allowed a self-metathesis with Grubbs II catalyst providing a ‘dimeric’ compound as an E/Z mixture. Its hydrogenolysis furnished the divalent C-aminoglycoside in good overall yield.

Key words

1,2-oxazine - pyran - C-glycoside - amino sugar - olefin metathesis - hydrogenation

Volltext

Referenzen

References and Notes

1a Plass W. Coord. Chem. Rev. 2009; 253: 2286
1b Ranjan N, Arya D. Molecules 2013; 18: 14228
1c Slattery CN, Clarke L.-A, Ford A, Maguire AR. Tetrahedron 2013; 69: 1297
1d Kumar S, Kellish P, Robinson WE, Wang D, Appella DH, Arya DP. Biochemistry 2012; 51: 2331
1e Xi H, Davis E, Ranjan N, Xue L, Hyde-Volpe D, Arya DP. Biochemistry 2011; 50: 9088
1f Pedersen CM, Olsen J, Brka AB, Bols M. Chem. Eur. J. 2011; 17: 7080

2a Becker B, Cooper MA. ACS Chem. Biol. 2013; 8: 105
2b Park SR, Park JW, Ban YH, Sohng JK, Yoon YJ. Nat. Prod. Rep. 2013; 30: 11
2c Hainrichson M, Nudelman I, Baasov T. Org. Biomol. Chem. 2008; 6: 227

3a Łysek R, Vogel P. Tetrahedron 2006; 62: 2733
3b Rai R, McAlexander I, Chang C.-WT. Org. Prep. Proced. Int. 2005; 37: 337
3c Herzog IM, Fridman M. MedChemComm 2014; 5: 1014

4 Helms M, Schade W, Pulz R, Watanabe T, Al-Harrasi A, Fišera L, Hlobilová I, Zahn G, Reissig H.-U. Eur. J. Org. Chem. 2005; 1003

5a Al-Harrasi A, Reissig H.-U. Angew. Chem. Int. Ed. 2005; 44: 6227 ; Angew. Chem. 2005, 117, 6383
5b Al-Harrasi A, Pfrengle F, Prisyazhnyuk V, Yekta S, Koóš P, Reissig H.-U. Chem. Eur. J. 2009; 15: 11632

6a Kandziora M, Reissig H.-U. Beilstein J. Org. Chem. 2014; 10: 1749
6b Kandziora M, Reissig H.-U. Eur. J. Org. Chem. 2014; early view: doi: 10.1002/ejoc.201403186

7a Pfrengle F, Reissig H.-U. Chem. Eur. J. 2010; 16: 11915
7b Pfrengle F, Lentz D, Reissig H.-U. Angew. Chem. Int. Ed. 2009; 48: 3165 ; Angew. Chem. 2009, 121, 3211

8a Pfrengle F, Reissig H.-U. Chem. Soc. Rev. 2010; 39: 549
8b Bouché L, Reissig H.-U. Pure Appl. Chem. 2012; 84: 23

9 Pfrengle F, Dekaris V, Schefzig L, Zimmer R, Reissig H.-U. Synlett 2008; 2965
10 Manzo E, Barone G, Parrilli M. Synlett 2000; 887
11 Bressel B, Egart B, Al-Harrasi A, Pulz R, Reissig H.-U, Brüdgam I. Eur. J. Org. Chem. 2008; 467
12 Pfrengle F, Al-Harrasi A, Brüdgam I, Reissig H.-U. Eur. J. Org. Chem. 2009; 282
13 Nishimura S. Handbook of Heterogeneous Catalytic Hydrogenation for Organic Synthesis. Wiley; New York: 2001
14 Bouché L, Kandziora M, Reissig H.-U. Beilstein J. Org. Chem. 2014; 10: 213

For reviews, see:

15a Dominique R, Das SK, Roy R. Chem. Commun. 1998; 2437
15b Leeuwenburgh MA, van der Marel GA, Overkleeft HS. Curr. Opin. Chem. Biol. 2003; 7: 757
15c Roy R, Das SK. Chem. Commun. 2000; 519

For selected original publications involving carbohydrate derivatives, see:

15d Roy R, Dominique R, Das SK. J. Org. Chem. 1999; 64: 5408
15e Godin G, Compain P, Martin OR. Org. Lett. 2003; 5: 3269
15f Khan SN, Kim A, Grubbs RH, Kwon Y.-U. Org. Lett. 2012; 14: 2952

16 Dias EL, Nguyen ST, Grubbs RH. J. Am. Chem. Soc. 1997; 119: 3887
17 Fürstner A, Langemann K. J. Am. Chem. Soc. 1997; 119: 9130
18 Majetich G, Hull K. Tetrahedron 1987; 43: 5621
19 Dekaris V, Pulz R, Al-Harrasi A, Lentz D, Reissig H.-U. Eur. J. Org. Chem. 2011; 3210

20a Smith GV, Notheisz F. Heterogeneous Catalysis in Organic Chemistry. Academic Press; Waltham (MA, USA): 1999
20b Fu X, Cook JM. J. Am. Chem. Soc. 1992; 114: 6910
20c Fu X, Cook JM. J. Org. Chem. 1993; 58: 661

21 Freeman DB, Holubec AA, Weiss MW, Dixon JA, Kakefuda A, Ohtsuka M, Inoue M, Vaswani RG, Ohki H, Doan BD, Reisman SE, Stoltz BM, Day JJ, Tao RN, Dieterich NA, Wood JL. Tetrahedron 2010; 66: 6647
22 Representative Experimental Procedures:(1R,5S,6S,8S,9R)-2-Benzyl-8-(hydroxymethyl)-6-vinyl-3,7-dioxa-2-azabicyclo[3.3.1]nonan-9-ol (7a) and (1R,5S,6S,8S,9S)-2-Benzyl-8-(hydroxymethyl)-6-vinyl-3,7-dioxa-2-azabicyclo[3.3.1]nonan-9-ol (7b): 1,2-Oxazine 2 (50 mg, 128 μmol) was dissolved in MeCN (2 mL) and cooled to 0 °C. Tin(IV) chloride (45 μL, 100 mg, 384 μmol) was added and the solution was stirred for 3 h at 0 °C, then additional tin(IV) chloride (45 μL, 100 mg, 384 μmol) was added and the reaction mixture was stirred for 18 h at r.t. H₂O (5 mL) was added and the aqueous layer was extracted with CH₂Cl₂ (5 × 10 mL). The combined organic layers were dried with Na₂SO₄, filtered and the solvent was removed in vacuo. The crude product was dissolved in EtOH (2 mL) and cooled to –30 °C. Sodium borohydride (10 mg, 256 μmol) was added and the suspension was stirred for 3 h at –30 °C. Then the solvent was removed in vacuo and the crude product was dissolved in CH₂Cl₂ (10 mL) and H₂O (5 mL) was added. The aqueous layer was extracted with CH₂Cl₂ (5 × 10 mL). The combined organic layers were dried with Na₂SO₄, filtered and the solvent was removed in vacuo. The crude product was purified by column chromatography (silica gel; hexanes–EtOAc, 1:4) to yield 7a (21 mg, 56%) and 7b(4 mg, 11%) as colorless solids.Data of 7a: mp 108–110 °C; [α]_D ²² +47.9 (c = 1.04, CHCl₃). ¹H NMR (500 MHz, CDCl₃): δ = 1.96 (m_c, 1 H, 5-H), 2.75 (br s, 1 H, OH), 3.11 (br s, 1 H, 1-H), 3.69, 3.73 (AB part of ABX system, J _AX = 4.6 Hz, J _BX = 6.6 Hz, J _AB = 11.0 Hz, 2 H, 8-CH₂), 3.70 (br s, 1 H, OH), 3.89 (br s, 1 H, 9-H), 3.99–4.03 (m, 1 H, 8-H), 4.09 (d, J = 14.1 Hz, 1 H, NCH₂), 4.16–4.18 (m, 1 H, 4-H), 4.17 (s, 1 H, 6-H), 4.19 (ddd, J = 0.6, 5.8, 12.1 Hz, 1 H, 4-H), 4.23 (d, J = 14.1 Hz, 1 H, NCH₂), 5.23 (br d, J = 10.8 Hz, 1 H, 2′-H), 5.36 (br d, J = 17.4 Hz, 1 H, 2′-H), 5.84 (ddd, J = 4.7, 10.8, 17.4 Hz, 1 H, 1′-H), 7.27–7.34 (m, 5 H, Ph). ¹³C NMR (125 MHz, CDCl₃): δ = 39.1 (d, C-5), 62.1 (d, C-1), 62.2 (t, NCH₂), 63.8 (t, 8-CH₂), 65.1 (t, C-4), 70.4 (d, C-9), 78.7 (d, C-6), 79.3 (d, C-8), 116.6 (t, C-2′), 127.7, 128.6, 128.8 (3 × d, Ph), 135.9 (d, C-1′), 137.2 (s, Ph). IR (ATR): 3580–3180 (O–H), 3025–3005 (=C–H), 2930–2855 (C–H), 1595 (C=C), 1455 (C–H), 1230 (C–O) cm^–1. HRMS (ESI–TOF): m/z [M + H]⁺ calcd for C₁₆H₂₂NO₄: 292.1549; found: 292.1542; m/z [M + Na]⁺ calcd for C₁₆H₂₁NNaO₄: 314.1368; found: 314.1366.Data of 7b: mp 55–58 °C; [α]_D ²² +12.8 (c = 0.40, CHCl₃). ¹H NMR (700 MHz, CDCl₃): δ = 1.79 (m_c, 1 H, 5-H), 2.81 (m_c, 1 H, 1-H), 3.79, 3.98 (AB part of ABX system, J _AX = 4.0 Hz, J _BX = 5.4 Hz, J _AB = 11.6 Hz, 2 H, 8-CH₂), 4.11 (dd, J = 2.0, 12.1 Hz, 1 H, 4-H), 4.12 (d, J = 13.4 Hz, 1 H, NCH₂), 4.16–4.18 (m, 2 H, 4-H, 8-H), 4.27 (d, J = 13.4 Hz, 1 H, NCH₂), 4.62 (t, J = 4.0 Hz, 1 H, 9-H), 4.74 (dd, J = 1.5, 3.5 Hz, 1 H, 6-H), 5.24 (br d, J = 10.8 Hz, 1 H, 2′-H), 5.42 (br d, J = 17.3 Hz, 1 H, 2′-H), 5.92 (ddd, J = 5.2, 10.8, 17.3 Hz, 1 H, 1′-H), 7.25–7.28, 7.31–7.34 (2 × m, 1 H, 4 H, Ph); signals for OH could not be detected. ¹³C NMR (175 MHz, CDCl₃): δ = 39.9 (d, C-5), 57.8 (t, NCH₂), 59.3 (d, C-1), 62.3 (d, C-9), 64.5 (t, C-4), 65.0 (t, 8-CH₂), 72.26 (d, C-6), 72.32 (d, C-8), 116.5 (t, C-2′), 124.9, 127.8, 128.7 (3 × d, Ph), 136.8 (d, C-1′), 136.9 (s, Ph). IR (ATR): 3425 (O–H), 3055–3030 (=C–H), 2950–2825 (C–H), 1645 (C=C), 1445 (C–H), 1250 (C–O) cm^–1. HRMS (ESI–TOF): m/z [M + H]⁺ calcd for C₁₆H₂₂NO₄: 292.1549; found: 292.1537; m/z [M + Na]⁺ calcd for C₁₆H₂₁NNaO₄: 314.1368; found: 314.1355. Anal. Calcd for C₁₆H₂₁NO₄ (291.3): C, 65.96; H, 7.27; N, 4.81. Found: C, 65.99; H, 7.22; N, 4.86.(1R,5R,6S,8S,9R)-2-Benzyl-9-(benzyloxy)-8-(benzyloxy-methyl)-6-vinyl-3,7-dioxa-2-azabicyclo[3.3.1]nonane (8): To a suspension of sodium hydride in mineral oil (15 mg, 60% NaH) in THF (1 mL) a solution of compound 7a (20 mg, 67 μmol) in THF (1 mL) was added dropwise at 0 °C. The reaction mixture was stirred for 1 h at r.t. and then cooled to 0 °C. Benzyl bromide (26 μL, 37 mg, 215 μmol) was added and the suspension was stirred for 18 h at r.t. The reaction was quenched with MeOH (1 mL) and the solvent was removed in vacuo. H₂O (5 mL) and EtOAc (10 mL) were added and the aqueous layer was extracted with EtOAc (3 × 10 mL). The combined organic layers were dried with Na₂SO₄, filtered through a pad of Celite^® and the solvent was removed in vacuo. The crude product was purified by column chromatography (silica gel; hexanes–EtOAc, 20:1) to yield 8 (30 mg, 95%) as a colorless solid; mp 45–47 °C; [α]_D ²² +53.5 (c = 1.10, CHCl₃). ¹H NMR (500 MHz, CDCl₃): δ = 1.75 (m_c, 1 H, 5-H), 2.98 (br s, 1 H, 1-H), 3.53 (br t, J = 2.8 Hz, 1 H, 9-H), 3.58 (br d, J = 11.7 Hz, 1 H, 4-H), 3.64, 3.70, 3.79 (ABX system, J _BX = 5.2 Hz, J _AX = 8.8 Hz, J _AB = 11.8 Hz, 3 H, 8-CH₂, 8-H), 4.15 (m_c, 1 H, 6-H), 4.21 (d, J = 13.7 Hz, 1 H, NCH₂Ph), 4.36, 4.42 (AB system, J _AB = 11.8 Hz, 2 H, OCH₂Ph), 4.43 (td, J = 1.9, 11.7 Hz, 1 H, 4-H), 4.50 (d, s, J = 13.7 Hz, 3 H, NCH₂Ph, OCH₂Ph), 5.10 (br d, J = 10.8 Hz, 1 H, 2′-H), 5.26 (br d, J = 17.3 Hz, 1 H, 2′-H), 5.81 (ddd, J = 5.1, 10.8, 17.3 Hz, 1 H, 1′-H), 7.04–7.07, 7.09–7.20, 7.21–7.28 (3 × m, 1 H, 10 H, 4 H, Ph). ¹³C NMR (125 MHz, CDCl₃): δ = 37.4 (d, C-5), 55.2 (d, C-1), 57.6 (t, C-4), 58.4 (t, NCH₂Ph), 60.5 (t, OCH₂Ph), 70.5, 70.6 (2 × t, OCH₂Ph, 8-CH₂), 73.7 (d, C-9), 78.3 (d, C-8), 79.0 (d, C-6), 116.6 (t, C-2′), 127.0, 127.4, 127.7, 127.9, 128.0, 128.2, 128.4, 128.7, 128.8 (9 × d, Ph), 136.2 (d, C-1′), 138.1, 138.3, 138.9 (3 × s, Ph). IR (ATR): 3060–3025 (=C–H), 2930–2870 (C–H), 1645 (C=C), 1450 (C–H), 1240 (C–O) cm^–1. HRMS (ESI–TOF): m/z [M + H]⁺ calcd for C₃₀H₃₄NO₄: 472.2488; found: 472.2524; (ESI–TOF): m/z [M + Na]⁺ calcd for C₃₀H₃₃NNaO₄: 494.2307; found: 494.2345.(2S,3R,4S,5S,6S)-(3-Amino-6-ethyl-4-hydroxytetrahydro-2H-pyran-2,5-diyl)dimethanol (9b): A suspension of Pd/C (10% Pd, 70 mg) and i-PrOH (3 mL) was saturated with hydrogen for 15 min. To this suspension bicyclic compound 7b (70 mg, 240 μmol), dissolved in i-PrOH (1 mL), was added. The mixture was stirred for 18 h under hydrogen pressure (balloon). Then the mixture was filtrated through a pad of Celite^®, the solvent was removed in vacuo and the crude material was purified by column chromatography (silica gel; CH₂Cl₂–MeOH, 10:1) to yield 9b (34 mg, 69%) as a colorless solid; mp 143–145 °C; [α]_D ²² +63.1 (c = 1.02, MeOH). ¹H NMR (700 MHz, CD₃OD): δ = 0.77 (t, J = 7.4 Hz, 3 H, 2′-H), 1.39–1.45 (m, 1 H, 1′-H), 1.56–1.62 (m, 2 H, 5-H, 1′-H), 2.91 (br s, 1 H, 3-H), 3.15 (m_c, 1 H, 6-H), 3.20 (br s, 1 H, 2-H), 3.37, 3.47 (AB part of ABX system, J _AX = 5.6 Hz, J _BX = 6.7 Hz, J _AB = 11.5 Hz, 2 H, 2-CH₂), 3.44 (dd, J = 2.9, 11.4 Hz, 1 H, 5-CH₂), 3.60 (br d, J ≈ 11.4 Hz, 1 H, 5-CH₂), 3.80 (br t, J = 5.2 Hz, 1 H, 4-H). ¹³C NMR (175 MHz, CD₃OD): δ = 11.3 (q, C-2′), 26.3 (t, C-1′), 44.6 (d, C-5), 51.0 (d, C-3), 55.6 (t, 5-CH₂), 62.9 (t, 2-CH₂), 72.2 (d, C-4), 79.7 (d, C-2), 82.1 (d, C-6). IR (ATR): 3365–3300 (O–H, N–H), 2960–2845 (C–H), 1460 (C–H) cm^–1. HRMS (ESI–TOF): m/z [M + H]⁺ calcd for C₉H₂₀NO₄: 206.1392; found: 206.1402; m/z [M + Na]⁺ calcd for C₉H₁₉NNaO₄: 228.1212; found: 228.1212.(E,1R,5R,6S,8S,9R)-1,2-Bis[2-benzyl-9-(benzyloxy)-8-(benzyloxymethyl)-3,7-dioxa-2-azabicyclo[3.3.1]nonan-6-yl]ethene (13a) and (Z,1R,5R,6S,8S,9R)-1,2-Bis-[2-benzyl-9-(benzyloxy)-8-(benzyloxymethyl)-3,7-dioxa-2-azabicyclo[3.3.1]-nonan-6-yl]ethane (13b): Benzyl-protected bicyclic compound 8 (300 mg, 636 μmol) was dissolved in degassed CH₂Cl₂ (5 mL). Grubbs II catalyst (18 mg, 21 μmol) was added to this solution and the mixture was stirred for 3 h at 40 °C. Then a second portion of Grubbs II catalyst (18 mg, 21 μmol) was added and after another 3 h of stirring at 40 °C a third portion of the catalyst (18 mg, 21 μmol) was added. The reaction mixture was stirred for 18 h at 40 °C. The solvent was removed in vacuo and the crude product was purified by column chromatography (silica gel; hexanes–EtOAc, 4:1) to yield 13a and 13b (165 mg, 57%, E-isomer; 117 mg, 40%, Z-isomer) as colorless oils.Data of E-isomer 13a: [α]_D ²² +66.1 (c = 1.04, CHCl₃). ¹H NMR (500 MHz, CDCl₃): δ = 1.95 (br s, 2 H, 5-H), 3.09 (br s, 2 H, 1-H), 3.66 (d, J = 1.9 Hz, 2 H, 9-H), 3.67 (d, J = 6.5 Hz, 2 H, 4-H), 3.77, 3.83, 3.90 (ABM part of ABMX system, J _MX = 5.2 Hz, J _BM = 6.4 Hz, J _AM = 8.8 Hz, J _AB = 11.6 Hz, 6 H, 8-H, 8-CH₂), 4.34 (br s, 2 H, 6-H), 4.39 (d, J = 13.5 Hz, 2 H, NCH₂Ph), 4.50, 4.56 (AB system, J _AB = 11.8 Hz, 4 H, OCH₂Ph), 4.53 (m_c, 2 H, 4-H), 4.58 (d, J = 13.5 Hz, 2 H, NCH₂Ph), 4.62, 4.65 (AB system, J _AB = 12.0 Hz, 4 H, OCH₂Ph), 5.96 (d, J = 1.5 Hz, 2 H, HC=CH), 7.20–7.36 (m, 20 H, Ph), 7.40–7.41 (m, 10 H, Ph). ¹³C NMR (125 MHz, CDCl₃): δ = 36.7 (d, C-5), 55.3 (d, C-1), 58.0 (t, C-4), 58.4 (t, NCH₂Ph), 70.5 (t, OCH₂Ph), 70.7 (t, 8-CH₂), 73.7 (t, OCH₂Ph), 76.1 (d, C-9), 77.9 (d, C-6), 78.3 (d, C-8), 127.1, 127.5, 127.7, 127.9, 128.2, 128.4, 128.7, 129.0 (8 × d, Ph), 129.3 (d, C=C), 138.1, 138.4, 138.8 (3 × s, Ph); one d for Ph could not be detected. IR (ATR): 3060–3030 (=C–H), 2920–2860 (C–H), 1735, 1660 (C=C), 1495 (C–H), 1240 (C–O) cm^–1. HRMS (ESI–TOF): m/z [M + H]⁺ calcd for C₅₈H₆₃N₂O₈: 915.4584; found: 915.4577; m/z [M + Na]⁺ calcd for C₅₈H₆₂N₂NaO₈: 937.4404; found: 937.4404. Anal. Calcd for C₅₈H₆₂N₂O₈ (915.1): C, 76.12; H, 6.83; N, 3.06. Found: C, 75.85; H, 7.20; N, 3.06.Data of Z-isomer 13b: [α]_D ²² +72.1 (c = 1.07, CHCl₃). ¹H NMR (500 MHz, CDCl₃): δ = 2.00 (m_c, 2 H, 5-H), 2.49 (s, 2 H, 1-H), 3.49 (t, J = 2.6 Hz, 2 H, 9-H), 3.58 (d, J = 11.8 Hz, 2 H, 4-H), 3.61, 3.70, 3.76 (ABM part of ABMX system, J _MX = 5.2 Hz, J _AM = 6.5 Hz, J _BM = 8.8 Hz, J _AB = 11.7 Hz, 6 H, 8-H, 8-CH₂), 4.23 (d, J = 13.7 Hz, 2 H, NCH₂Ph), 4.33, 4.38 (AB system, J _AB = 11.8 Hz, 4 H, OCH₂Ph), 4.44, 4.52 (AB system, J _AB = 11.8 Hz, 4 H, OCH₂Ph), 4.45–4.48 (m, 2 H, 4-H), 4.50 (d, J = 13.7 Hz, 2 H, NCH₂Ph), 4.54 (s, 2 H, 6-H), 5.65 (d, J = 3.6 Hz, 2 H, HC=CH), 7.05–7.27 (m, 30 H, Ph). ¹³C NMR (125 MHz, CDCl₃): δ = 36.9 (d, C-5), 55.4 (d, C-1), 57.7 (t, C-4), 58.4 (t, NCH₂Ph), 70.4 (t, OCH₂Ph), 70.8 (t, 8-CH₂), 73.7 (t, OCH₂Ph), 75.9 (d, C-9), 76.3 (d, C-6), 78.2 (d, C-8), 127.0, 127.4, 127.9, 128.0, 128.2, 128.5, 128.7, 128.8 (8 × d, Ph), 130.6 (d, C=C), 138.2, 138.3, 138.9 (3 × s, Ph); one d for Ph could not be detected. IR (ATR): 3085–3030 (=C–H), 2965–2855 (C–H), 1735, 1655 (C=C), 1495 (C–H), 1230 (C–O) cm^–1. HRMS (ESI–TOF): m/z [M + H]⁺ calcd for C₅₈H₆₃N₂O₈: 915.4584; found: 915.4585; m/z [M + Na]⁺ calcd for C₅₈H₆₂N₂NaO₈: 937.4404; found: 937.4407. Anal. Calcd for C₅₈H₆₂N₂O₈ (915.1): C, 76.12; H, 6.83; N, 3.06. Found: C, 75.33; H, 7.42; N, 3.06.Divalent C-Aminoglycoside 14: A suspension of Pd/C (10% Pd, 330 mg), MeOH (35 mL) and acetic acid (108 mg, 103 μL, 1.80 mmol) was saturated with hydrogen for 15 min. The bicyclic compound 13a (165 mg, 180 µmol) was dissolved in MeOH (2 mL), and added to the suspension. The mixture was stirred for 3 d under hydrogen pressure (balloon). The mixture was filtered through a pad of Celite^® and the solvent was removed in vacuo. The crude product was dissolved in MeOH (1 mL), hydroxylamine hydrochloride (55 mg, 791 μmol) was added and the reaction mixture was stirred for 30 min at 65 °C. The solvent was removed in vacuo, the crude product was dissolved in MeOH (0.5 mL) and EtOAc (0.5 mL) was added. The precipitated solid was filtered off, washed with EtOAc (3 × 1 mL) and dried in vacuo to yield 14 (41 mg, 60%; for numbering see Figure 1) as a brownish solid. Since the product is highly hygroscopic no melting point was determined.[α]_D ²² –5.0 (c = 0.60, MeOH). ¹H NMR (700 MHz, CD₃OD): δ = 1.71–1.76 (m, 2 H, CH₂), 1.98 (ddd, J = 1.6, 3.1, 5.9 Hz, 2 H, 5-H), 2.10–2.15 (m, 2 H, CH₂), 3.52 (dd, J = 1.5, 4.4 Hz, 2 H, 3-H), 3.63, 3.80, 3.85 (ABX part of ABXY system, J _XY = 1.5 Hz, J _AX = J _BX = 4.9 Hz, J _AB = 11.8 Hz, 6 H, 2-H, 2-CH₂), 3.69–3.70 (m, 2 H, 6-H), 3.88, 3.97 (AB part of ABX system, J _AX = 1.6 Hz, J _BX = 3.1 Hz, J _AB = 11.5 Hz, 4 H, 5-CH₂), 4.32 (dd, J = 4.4, 7.0 Hz, 2 H, 4-H). ¹³C NMR (175 MHz, CD₃OD): δ = 29.8 (t, CH₂), 44.0 (d, C-5), 52.3 (d, C-3), 55.2 (t, 5-CH₂), 63.2 (t, 2-CH₂), 68.9 (d, C-4), 77.0 (d, C-2), 80.3 (d, C-6). IR (ATR): 3310 (O–H, N–H), 2935 (C–H), 1235 (C–O) cm^–1. HRMS (ESI–TOF): m/z [M + H]⁺ calcd for C₁₆H₃₃N₂O₈: 381.2237; found: 381.2235; m/z [M + Na]⁺ calcd for C₁₆H₃₂N₂NaO₈: 403.2056; found: 403.2041.

Zusatzmaterial

Supporting Information